Year: 2015
Type: article
Study design: Clinical Trial
Abstract: Studies using outpatient closed-loop in-sulin delivery for type 1 diabetes have recently been published (1–5). We conducted a 5-day outpatient feasibility study comparing hybrid closed-loop (HCL) to sensor-augmented pump therapy with low-glucose suspend (SAPT1 LGS) in eight patients with type 1 diabetes using an open-label randomized crossover trial
Source: Diabetes Care
DOI: 10.2337/dc15-1047
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Eli Lilly and Company, Sanofi, Novo Nordisk
OpenAlex ID: W1835735948
